Rare diseases
Investigational molecules
Locations
A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
CzechiaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
CzechiaA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
CzechiaLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
CzechiaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
CzechiaA study of navenibart for long-term safety in patients with hereditary angioedema
CzechiaA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
CzechiaA study testing duvakitug for patients with moderately to severely active ulcerative colitis
CzechiaA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
CzechiaA Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is
CzechiaA Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread
CzechiaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.
